Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Eton Pharmaceuticals Inc. (ETON:NASDAQ), powered by AI.
Eton Pharmaceuticals Inc. is currently trading at $31.59. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Eton Pharmaceuticals Inc. on Alpha Lenz.
View Eton Pharmaceuticals Inc.'s valuation metrics on Alpha Lenz.
“Eton Pharmaceuticals Inc.'s ROE is -18.2%. Explore profitability and growth together.”
Ask for details →Eton Pharmaceuticals Inc. is a specialty pharmaceutical company that focuses on the development and commercialization of innovative prescription products. Its primary function is to address unmet needs in the pharmaceutical landscape, particularly targeting rare diseases and niche therapy areas. Eton's strategy revolves around reformulating and enhancing existing drugs for better efficacy, safety, and patient compliance. The company's portfolio includes products across various medical fields, such as endocrinology, oncology, and neurology, enhancing the lives of patients with conditions often overlooked by larger pharmaceutical firms. Established in the United States, Eton Pharmaceuticals plays a crucial role in the healthcare sector by providing solutions that may not receive significant attention from larger players in the market. Through strategic partnerships and a focus on underserved patient populations, Eton contributes to the diversification and innovation of treatment options available in the pharmaceutical industry.
“Eton Pharmaceuticals Inc.'s ROE is -18.2%. Explore profitability and growth together.”
Ask for details →Eton Pharmaceuticals Inc. (ticker: ETON) is a company listed on NASDAQ in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 31 employees.
The current price is $31.59 with a P/E ratio of -x and P/B of -x.
ROE is -18.19% and operating margin is -1.06%. Annual revenue is $80M.